ENBIO Co., Ltd. (KOSDAQ: 352940)
South Korea
· Delayed Price · Currency is KRW 2,120.00
-40.00 (-1.85%)
Dec 20, 2024, 9:00 AM KST
ENBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 35,037 | 34,024 | 34,240 | 33,466 | 34,563 | 33,736 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | - | - | Upgrade
|
| Revenue | 35,037 | 34,024 | 34,240 | 33,466 | 34,563 | 33,736 | Upgrade
|
| Revenue Growth (YoY) | 3.39% | -0.63% | 2.31% | -3.17% | 2.45% | 11.24% | Upgrade
|
| Cost of Revenue | 27,065 | 26,970 | 27,898 | 22,713 | 20,231 | 21,159 | Upgrade
|
| Gross Profit | 7,973 | 7,055 | 6,342 | 10,753 | 14,332 | 12,577 | Upgrade
|
| Selling, General & Admin | 9,270 | 9,052 | 8,859 | 7,562 | 6,777 | 6,371 | Upgrade
|
| Research & Development | 578.48 | 578.48 | 523.54 | 387.91 | 469.14 | 450.12 | Upgrade
|
| Other Operating Expenses | 44.43 | 44.43 | 46.41 | 45.36 | 45.2 | 53.47 | Upgrade
|
| Operating Expenses | 10,331 | 10,408 | 11,119 | 9,631 | 10,237 | 8,128 | Upgrade
|
| Operating Income | -2,358 | -3,354 | -4,777 | 1,122 | 4,096 | 4,449 | Upgrade
|
| Interest Expense | -2,449 | -2,449 | -2,104 | -818.65 | -801.02 | -2,398 | Upgrade
|
| Interest & Investment Income | 111.08 | 347.08 | 256.72 | 96.61 | 36.2 | 70.33 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -169.27 | 21.35 | -91.68 | Upgrade
|
| Other Non Operating Income (Expenses) | 2,086 | -1,141 | 2,793 | 6,158 | -8,113 | -720 | Upgrade
|
| EBT Excluding Unusual Items | -2,610 | -6,597 | -3,832 | 6,389 | -4,761 | 1,310 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 141.07 | 14.95 | - | Upgrade
|
| Asset Writedown | - | - | - | -401.93 | -220.4 | -131.6 | Upgrade
|
| Other Unusual Items | -1,463 | -1,463 | - | - | - | - | Upgrade
|
| Pretax Income | -4,073 | -8,060 | -3,832 | 6,128 | -4,966 | 1,178 | Upgrade
|
| Income Tax Expense | -861.55 | -1,760 | -387.14 | 882.84 | -516.73 | 157.99 | Upgrade
|
| Net Income | -3,212 | -6,300 | -3,445 | 5,245 | -4,449 | 1,020 | Upgrade
|
| Net Income to Common | -3,212 | -6,300 | -3,445 | 5,245 | -4,449 | 1,020 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 8 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 8 | 3 | Upgrade
|
| Shares Change (YoY) | -2.01% | 0.01% | -3.41% | 36.03% | 167.50% | 1287.08% | Upgrade
|
| EPS (Basic) | -296.89 | -579.73 | -317.00 | 492.55 | -538.00 | 452.00 | Upgrade
|
| EPS (Diluted) | -296.89 | -579.73 | -317.00 | 344.00 | -538.00 | 330.00 | Upgrade
|
| Free Cash Flow | 3,570 | 10,766 | -8,679 | -5,205 | 3,487 | -1,206 | Upgrade
|
| Free Cash Flow Per Share | 330.02 | 990.64 | -798.65 | -462.61 | 421.64 | -390.14 | Upgrade
|
| Gross Margin | 22.75% | 20.73% | 18.52% | 32.13% | 41.47% | 37.28% | Upgrade
|
| Operating Margin | -6.73% | -9.86% | -13.95% | 3.35% | 11.85% | 13.19% | Upgrade
|
| Profit Margin | -9.17% | -18.52% | -10.06% | 15.67% | -12.87% | 3.02% | Upgrade
|
| Free Cash Flow Margin | 10.19% | 31.64% | -25.35% | -15.55% | 10.09% | -3.58% | Upgrade
|
| EBITDA | 581.72 | -746.91 | -2,538 | 3,411 | 6,272 | 6,363 | Upgrade
|
| EBITDA Margin | 1.66% | -2.20% | -7.41% | 10.19% | 18.15% | 18.86% | Upgrade
|
| D&A For EBITDA | 2,940 | 2,607 | 2,239 | 2,289 | 2,177 | 1,914 | Upgrade
|
| EBIT | -2,358 | -3,354 | -4,777 | 1,122 | 4,096 | 4,449 | Upgrade
|
| EBIT Margin | -6.73% | -9.86% | -13.95% | 3.35% | 11.85% | 13.19% | Upgrade
|
| Effective Tax Rate | - | - | - | 14.41% | - | 13.41% | Upgrade
|
| Advertising Expenses | - | 268.31 | 271.48 | 197.66 | 83.57 | 63.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.